Alto Neuroscience Inc. (ANRO)
Alto Neuroscience, Inc. - Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
Alto Neuroscience, Inc. - Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
Natera - Two Publications Highlight Clinical Utility ofSignatera™ in Anal and Rectal Cancers
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
Townsquare Reports Q4 and Year End Results; Maintains Current Dividend, Reflecting an 11% Yield Today
Snowline Gold Announces Inclusion Into the GDXJ
Mawson Infrastructure Group Inc. Provides Update on Strategic Initiatives
KE Holdings Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and a Final Cash Dividend
Maple Partners with Shift4 to Bring AI Phone Ordering to SkyTab Restaurants
Two Publications Highlight Clinical Utility of Signatera™ in Anal and Rectal Cancers
WaterBridge Announces Fourth Quarter and Fiscal Year 2025 Results
NUBURU Issues Letter to its Shareholders
WisdomTree to Acquire Atlantic House Holdings Limited, Expanding Global ETF Lineup with Defined Outcome and Derivatives Capabilities